FAS and cancer: Another proposed mechanism is the increased surface MHC class I expression and Fas/CD95 interaction that are able to increase rejection of the irradiated tumor by adoptively transferred T-cells, with alterations in the post-radiation transcriptome resulting in changes of the antigenic capabilities by the cancer cells on MHC class 1 [14].